NIAID-developed vaccine for mosquito-borne viruses found safe in trial - Clinical Trials Arena

The US National Institutes of Health (NIH) has reported findings from a Phase I clinical trial where the vaccine candidate, WEVEE, for rare, deadly mosquito-borne viruses was demonstrated to

The US National Institutes of Health (NIH) has reported findings from a Phase I clinical trial where the vaccine candidate, WEVEE, for rare, deadly mosquito-borne viruses was demonstrated to be safe … [+2088 chars]

full article...